A detailed history of Peak6 Investments LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Peak6 Investments LLC holds 7,500 shares of AXSM stock, worth $672,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,500
Previous 14,900 49.66%
Holding current value
$672,300
Previous $1.19 Million 49.29%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$69.39 - $97.64 $4,371 - $6,151
63 Added 3.01%
2,154 $171,000
Q4 2023

Feb 13, 2024

BUY
$57.42 - $83.61 $120,065 - $174,828
2,091 New
2,091 $166,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.84B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.